Active	Status	Sponsor type	Region	Phase	Filter
3 Active 0 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Tabrizi, Sarah
PIVOT-HD, NCT05358717 / 2021-003852-18: A Study to Evaluate the Safety and Efficacy of PTC518 in Participants With Huntington's Disease (HD)	Active, not recruiting	2	252	Europe, Canada, US, RoW	PTC518, Placebo	PTC Therapeutics, PTC Therapeutics, Inc.	Huntington Disease	02/25	08/25
CT-AMT-130-02, NCT05243017 / 2020-001461-36: Safety and Efficacy of AMT-130 in European Adults with Early Manifest Huntington's Disease	Active, not recruiting	1/2	14	Europe	intra-striatal rAAV5-miHTT, AMT-130	UniQure Biopharma B.V., uniQure biopharma B.V.	Huntington Disease	03/29	10/29
NCT01574053: Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort	Recruiting	N/A	35000	Europe, Canada, US, RoW		CHDI Foundation, Inc.	Huntington's Disease	01/62	01/62